文献速递神经胸部MR

扩散张量和增强T1加权成像放射组学鉴别非小细胞肺癌脑转移的表皮生长因子受体突变状态

Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer.
PubMed 文献 · Neuroradiology · 2020-08-21

研究纳入51例非小细胞肺癌脑转移患者共99个病灶,从术前增强T1加权和扩散张量成像提取526个放射组学特征构建分类器,最佳分类器在测试集鉴别表皮生长因子受体突变状态的AUC为0.73、准确率78.6%、敏感度81.3%、特异度76.9%。

要点

  • 增强T1加权与扩散张量成像放射组学特征可用于鉴别非小细胞肺癌脑转移的表皮生长因子受体突变状态。
  • 最佳分类器由基于树的特征选择与线性判别算法组合构建,共选用5个特征。
  • 原发瘤与脑转移灶之间表皮生长因子受体突变状态总体不一致率为12%。

核心结论

  • 整合多参数MRI的放射组学分类器可能在鉴别非小细胞肺癌脑转移的表皮生长因子受体突变状态方面有潜力。

研究设计与样本

  • 回顾性纳入51例非小细胞肺癌脑转移患者共99个脑转移灶,均经手术或活检且已知表皮生长因子受体突变状态。
  • 病灶分为训练集57个(31例患者)与测试集42个(20例患者),表皮生长因子受体野生型57个、突变型42个。
  • 从术前增强T1加权和扩散张量成像提取526个放射组学特征,由5种特征选择器与4种机器学习算法组合构建分类器,以受试者工作特征曲线下面积评估性能。

诊断标准与关键数值

  • 最佳分类器为基于树的特征选择联合线性判别算法,选用5个特征(1个来自表观扩散系数、2个来自各向异性分数、2个来自增强T1加权图像)。
  • 该分类器在测试集鉴别表皮生长因子受体突变状态的AUC为0.73,准确率78.6%,敏感度81.3%,特异度76.9%。

临床应用与阅片要点

  • 原发瘤与脑转移灶之间表皮生长因子受体突变状态总体不一致率为12%,提示评估脑转移灶自身影像特征具有意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess whether the radiomic features of diffusion tensor imaging (DTI) and conventional postcontrast T1-weighted (T1C) images can differentiate the epidermal growth factor receptor (EGFR) mutation status in brain metastases from non-small cell lung cancer (NSCLC).

METHODS: A total of 99 brain metastases in 51 patients who underwent surgery or biopsy with underlying NSCLC and known EGFR mutation statuses (57 from EGFR wild type, 42 from EGFR mutant) were allocated to the training (57 lesions in 31 patients) and test (42 lesions in 20 patients) sets. Radiomic features (n = 526) were extracted from preoperative MR images including T1C and DTI. Radiomics classifiers were constructed by combinations of five feature selectors and four machine learning algorithms. The trained classifiers were validated on the test set, and the classifier performance was assessed by determining the area under the curve (AUC).

RESULTS: EGFR mutation status showed an overall discordance rate of 12% between the primary tumors and corresponding brain metastases. The best performing classifier was a combination of the tree-based feature selection and linear discriminant algorithm and 5 features were selected (1 from ADC, 2 from fractional anisotropy, and 2 from T1C images), resulting in an AUC, accuracy, sensitivity, and specificity of 0.73, 78.6%, 81.3%, and 76.9% in the test set, respectively.

CONCLUSIONS: Radiomics classifiers integrating multiparametric MRI parameters may have potential in differentiating the EGFR mutation status in brain metastases from NSCLC.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Park YW, An C, Lee J, et al. Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer. Neuroradiology. 2020. PMID: 32827069. doi:10.1007/s00234-020-02529-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。